Literature DB >> 3103723

T-cell prolymphocytic leukemia (T-PLL) with unique surface phenotype.

J Lohmeyer, M Hadam, A Ho, A Hesse, H Pralle.   

Abstract

Leukemic cells of a 19 year old patient with prolymphocytic leukemia of T-cell type (T-PLL) were characterized by surface markers and immunologic functions. Phenotypic analysis using a large panel of monoclonal antibodies corresponding to the clusters (CD) of differentiation antigens established on the Leukocyte Typing Workshops I and II revealed a unique T-cell phenotype not yet reported in the literature: CD1 (T6)-, CD2 (T11)+, CD3 (T3)+, CD4 (T4)-, CD5 (T1)-, CD6 (T411)+, CD7 (Leu9)+, CD8 (T811)-, CD10 (J5)-, CD11 (M22)+, CD12 (M67)-, CD13 (My7)-, CD14 (Mo2)-, CD16 (Vep13, 3G8, Leu11)+, CD18 (MHM23)+, CD19 (B4)-, CD20 (B1)-, CD25 (TAC)-, MHC-class II (HLA-DR, HLA-DQ)-, NKH1A+, Leu7-. Despite the expression of surface structures associated with natural killer (NK) function (CD16, CD18, NKH 1 A) the T-PLL cells were inactive in NK assays in vitro. Low in vitro ADCC activity was detectable. This unusual T-PLL phenotype might help to identify a new distinct T-cell differentiation stage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103723     DOI: 10.1007/bf00594197

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Identification of a putative second T-cell receptor.

Authors:  M B Brenner; J McLean; D P Dialynas; J L Strominger; J A Smith; F L Owen; J G Seidman; S Ip; F Rosen; M S Krangel
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

2.  Prolymphocytic leukaemia.

Authors:  D A Galton; J M Goldman; E Wiltshaw; D Catovsky; K Henry; G J Goldenberg
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

3.  Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Authors:  T Hercend; J D Griffin; A Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

4.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia.

Authors:  G S Wood; D G Deneau; R A Miller; R Levy; R T Hoppe; R A Warnke
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

6.  Human T cell differentiation antigens characterizing a cytotoxic/suppressor T cell subset.

Authors:  P Rieber; J Lohmeyer; D J Schendel; G Riethmüller
Journal:  Hybridoma       Date:  1981

7.  Interleukin 2 promotes growth and cytolytic activity in human T3+4-8- thymocytes.

Authors:  A de la Hera; M L Toribio; C Marquez; C Martinez
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  A human lymphocyte-associated antigen involved in cell-mediated lympholysis.

Authors:  J E Hildreth; F M Gotch; P D Hildreth; A J McMichael
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

9.  A subset of human cells isolated and characterized by monoclonal antibodies.

Authors:  J Lohmeyer; P Rieber; H Feucht; J Johnson; M Hadam; G Riethmüller
Journal:  Eur J Immunol       Date:  1981-12       Impact factor: 5.532

10.  Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia.

Authors:  H C Rümke; F Miedema; I J ten Berge; F Terpstra; H J van der Reijden; R J van de Griend; H G de Bruin; A E von dem Borne; J W Smit; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.